RxDoctor Payments Data

Helen Hayes

Psychiatric/Mental Health · Indian Trail, NCNPI 1679580278

Payments from drug & device makers

$2,365in general payments, 2019–2025

Across 94 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$484
  • Otsuka America Pharmaceutical, Inc.$400
  • Teva Pharmaceuticals USA, Inc.$132
  • E.r. Squibb & Sons, L.L.C.$100
  • Indivior Inc.$31
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$2,20893%
  • Education$1577%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,365 in reported general payments places this provider in the 80th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$16,201
Medicare patients
27
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl22$33,636
Atomoxetine Hcl44$6,629
Oxcarbazepine98$4,234
Divalproex Sodium ErDivalproex Sodium60$2,113
Venlafaxine Hcl ErVenlafaxine Hcl99$2,003
Quetiapine Fumarate142$1,765
Aripiprazole26$1,748
Ziprasidone Hcl11$1,534
Naltrexone Hcl26$1,505
Fluvoxamine Maleate19$1,485
Bupropion XlBupropion Hcl60$1,411
Risperidone105$1,310
Benztropine Mesylate87$1,188
Mirtazapine60$957
Doxepin Hcl12$741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$484$33,63622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Indian Trail

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →